Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance
Function · 01.08.2026 · 7 (4)
DOI: 10.1152/function.039.2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Function, erschienen am 01.08.2026. Verfasst von Erik D Marchant und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Integrative Physiology, Long School of Medicine, University of Texas at San Antonio, San Antonio, Texas, United States. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Muscle, Skeletal, Inflammation, Glucose Intolerance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Chronic skeletal muscle mTORC1 hyperactivation is widely assumed to drive insulin resistance and metabolic decline, yet direct causal evidence remains limited. Using adult-onset Depdc5 deletion to constitutively activate mTORC1 via GATOR1 disruption, we show that this is insufficient to impair glucose homeostasis even under a Western diet challenge. Strikingly, glucose tolerance and mitochondrial respiration remained preserved despite inflammation and immune transcriptional reprogramming—challenging the prevailing model of mTORC1-driven metabolic dysfunction in muscle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Integrative Physiology, Long School of Medicine, University of Texas at San Antonio, San Antonio, Texas, United States.
- Barshop Institute for Longevity and Aging Studies, University of Texas at San Antonio, San Antonio, Texas, United States.
- Greehey Children's Cancer Research Institute, University of Texas at San Antonio, San Antonio, Texas, United States.
- Department of Molecular Medicine, Long School of Medicine, University of Texas at San Antonio, San Antonio, Texas, United States.
ORCID-Profile: Blake B Rasmussen
Förderung
- NCI NIH HHS
- NIH HHS
- NIA NIH HHS
- CPRIT
- NIH/NCI
- NIH
- NIH/NIA
Zitieren
APA
Marchant, E. D., Kalenta, H., Kilroe, S. P., May, J., Martini, W. Z., Weldon, K. S., Lai, Z., & Rasmussen, B. B. (2026). Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance. Function, 7(4). https://doi.org/10.1152/function.039.2026
Vancouver
Marchant ED, Kalenta H, Kilroe SP, May J, Martini WZ, Weldon KS, et al. Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance. Function. 2026;7(4). doi:10.1152/function.039.2026
BibTeX
@article{Marchant2026,
author = {Marchant, Erik D and Kalenta, Hanna and Kilroe, Sean P and May, Jacquelyn and Martini, Wenjun Z and Weldon, Korri S and Lai, Zhao and Rasmussen, Blake B},
title = {Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance},
journal = {Function},
year = {2026},
volume = {7},
number = {4},
doi = {10.1152/function.039.2026}
}
EUVIMED